Severe neuromyelitis optica spectrum disorder induced by pucotenlimab: a case report and literature review
Immune checkpoint inhibitors (ICIs) have been widely utilized in patients with cancer and established as a standard therapeutic modality for various solid tumors. Although generally well tolerated, ICIs can induce unique immune-related adverse events (…